Ładuje się......
Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer’s disease
Several potential disease-modifying drugs for Alzheimer’s disease (AD) have failed to show any effect on disease progression in clinical trials, conceivably because the AD subjects are already too advanced to derive clinical benefit from treatment and because diagnosis based on clinical criteria alo...
Zapisane w:
| Wydane w: | Alzheimers Dement |
|---|---|
| Główni autorzy: | , , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
2014
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4386839/ https://ncbi.nlm.nih.gov/pubmed/24795085 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jalz.2014.02.004 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|